Human GNLY/Granulysin ELISA Kit0 Publications

カタログ番号: KE00200

--

(希望販売価格)

容量: 1 Kit (96 assays)

販売および在庫状況はコスモ・バイオ(株)にお問い合わせください。
distributor

Images See all

概要


製品名:
Human GNLY/Granulysin ELISA Kit

試験方法:
1 X 96 well plate

測定サンプル対象:
Serum, Plasma, Cell culture supernatants

アッセイ方法:
Sandwich

感度:
0.6 pg/mL

測定範囲:
7.8-500 pg/mL

測定可能動物種:
Human

適用アプリケーション:
Sandwich ELISA

回収率:
Sample TypeAverageRange
Human serum 97% 80%-111%
Cell culture supernatants 82% 75%-98%

IntraAssay:
Samplenmean (pg/mL)SDCV%
1 20 259.2 9.5 3.7
2 20 66.1 1.9 2.9
3 20 14.8 0.5 3.2

InterAssay:
Samplenmean (pg/mL)SDCV%
1 24 262.6 13.7 5.2
2 24 60.8 3.9 6.4
3 24 13.2 0.7 5.5

製品概要
KE00200 is a solid phase sandwich Enzyme Linked-Immuno-Sorbent Assay (Sandwich ELISA). The GNLY/Granulysin ELISA kit is to be used to detect and quantify protein levels of endogenous GNLY/Granulysin. The assay recognizes human GNLY/Granulysin. An antibody specific for GNLY/Granulysin has been pre-coated onto the microwells. The GNLY/Granulysin protein in samples is captured by the coated antibody after incubation. Following extensive washing, another antibody of biotinylated specific for GNLY/Granulysin is added to detect the captured GNLY/Granulysin protein. For signal development, Streptavidin-HRP is added, followed by Tetramethyl-benzidine (TMB) reagent. Solution containing sulfuric acid is used to stop color development and the color intensity which is proportional to the quantity of bound protein is measurable at 450 nm with the correction wavelength set at 630 nm.

製品特性


保存方法:
All the reagents are stored at 2-8℃ for 6 months or -20℃ for 12 months. Refer to the protocol for further storage instructions.

別名:
519, D2S69E, GNLY, granulysin, LAG 2, LAG2, Lymphokine LAG 2, NKG5, Protein NKG5, T cell activation protein 519, TLA519
背景説明

Granulysin (GNLY) is a member of the saposin-like protein (SAPLIP) family that is a cytolytic and proinflammatory molecule expressed by activated human cytotoxic T cells and NK cells, exhibiting lytic activity against a variety of microorganisms and tumors. Granulysin is produced as an intact 15-kDa form, and portions are then cleaved at the amino and carboxy termini to produce a 9-kDa form. Granulysin has broad clinical relevance to a wide variety of diseases, including infections, cancer, transplantation, skin afflictions and reproductive complications. Elevation of Granulysin expression and levels in tissue and serum has been reported in infections, autoimmune diseases, transplant rejection. Granulysin expression has been widely correlated with good outcomes in a variety of cancers.


Back
to top